Business Description
PharmaCorp Rx Inc
NAICS : 551112
SIC : 7215
ISIN : CA74373X1015
Compare
Compare
Traded in other countries / regions
PCRX.Canada IPO Date
2022-05-16Description
PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 26.97 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.49 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 19.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.23 | |||||
| 9-Day RSI | 39 | |||||
| 14-Day RSI | 39.64 | |||||
| 6-1 Month Momentum % | 200 | |||||
| 12-1 Month Momentum % | 200 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 42.65 | |||||
| Quick Ratio | 42.13 | |||||
| Cash Ratio | 41.68 | |||||
| Days Inventory | 79.34 | |||||
| Days Sales Outstanding | 37.55 | |||||
| Days Payable | 86.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -43.77 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.85 | |||||
| Operating Margin % | -156.85 | |||||
| Net Margin % | -142.65 | |||||
| FCF Margin % | -91.68 | |||||
| ROE % | -16.84 | |||||
| ROA % | -15.71 | |||||
| ROIC % | -118.01 | |||||
| ROC (Joel Greenblatt) % | -446.97 | |||||
| ROCE % | -17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 34.67 | |||||
| PB Ratio | 2.04 | |||||
| Price-to-Tangible-Book | 2.36 | |||||
| EV-to-EBIT | -16.5 | |||||
| EV-to-EBITDA | -17.3 | |||||
| EV-to-Revenue | 24.86 | |||||
| EV-to-FCF | -28.73 | |||||
| Price-to-Net-Current-Asset-Value | 2.48 | |||||
| Price-to-Net-Cash | 2.48 | |||||
| Earnings Yield (Greenblatt) % | -6.06 | |||||
| FCF Yield % | -2.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmaCorp Rx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 1.395 | ||
| EPS (TTM) (C$) | -0.03 | ||
| Beta | 0 | ||
| Volatility % | 163.87 | ||
| 14-Day RSI | 39.64 | ||
| 14-Day ATR (C$) | 0.0437 | ||
| 20-Day SMA (C$) | 0.58 | ||
| 12-1 Month Momentum % | 200 | ||
| 52-Week Range (C$) | 0.21 - 0.875 | ||
| Shares Outstanding (Mil) | 115.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmaCorp Rx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmaCorp Rx Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmaCorp Rx Inc Frequently Asked Questions
What is PharmaCorp Rx Inc(TSXV:PCRX)'s stock price today?
The current price of TSXV:PCRX is C$0.52. The 52 week high of TSXV:PCRX is C$0.88 and 52 week low is C$0.21.
When is next earnings date of PharmaCorp Rx Inc(TSXV:PCRX)?
The next earnings date of PharmaCorp Rx Inc(TSXV:PCRX) is .
Does PharmaCorp Rx Inc(TSXV:PCRX) pay dividends? If so, how much?
PharmaCorp Rx Inc(TSXV:PCRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers